Oncologic outcomes after nipple-sparing mastectomy: A single-institution experience
Introduction Long‐term oncologic outcomes in nipple‐sparing mastectomy (NSM) continue to be defined. Rates of locoregional recurrence for skin‐sparing mastectomy (SSM) and NSM in the literature range from 0% to 14.3%. We investigated the outcomes of NSM at our institution. Methods Patients undergoin...
Gespeichert in:
Veröffentlicht in: | Journal of surgical oncology 2016-01, Vol.113 (1), p.8-11 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Introduction
Long‐term oncologic outcomes in nipple‐sparing mastectomy (NSM) continue to be defined. Rates of locoregional recurrence for skin‐sparing mastectomy (SSM) and NSM in the literature range from 0% to 14.3%. We investigated the outcomes of NSM at our institution.
Methods
Patients undergoing NSM at our institution from 2006 to 2014 were identified and outcomes were analyzed.
Results
From 2006 to 2014, 319 patients (555 breasts) underwent NSM. One‐hundered and fourty‐one patients (237 breasts) had long‐term follow‐up available. Average patient age and BMI were 47.78 and 24.63. Eighty‐four percent of patients underwent mastectomy primarily for a therapeutic indication. Average tumor size was 1.50 cm with the most common histologic type being invasive ductal carcinoma (62.7%) followed by DCIS (23.7%). Average patient follow‐up was 30.73 months. There was one (0.8%) incidence of ipsilateral chest‐wall recurrence. There were 0.37 complications per patient.
Conclusions
We examined our institutional outcomes with NSM and found a locoregional recurrence rate of 0.8% with no nipple‐areolar complex recurrence. This rate is lower than published rates for both NSM and SSM. J. Surg. Oncol. 2016;113:8–11. © 2015 Wiley Periodicals, Inc. |
---|---|
ISSN: | 0022-4790 1096-9098 |
DOI: | 10.1002/jso.24097 |